Hrubá marža spoločnosti SinoMab BioScience
Aká je hodnota metriky Hrubá marža spoločnosti SinoMab BioScience?
Hodnota metriky Hrubá marža spoločnosti SinoMab BioScience Limited je 78.59%
Aká je definícia metriky Hrubá marža?
Hrubá marža (Gross margin) je rozdiel medzi príjmami a nákladmi na predaný tovar vydelený príjmami a vyjadrený v percentách.
Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.
Hrubá marža spoločností v sektore Health Care sektor na HKSE v porovnaní so spoločnosťou SinoMab BioScience
Čomu sa venuje spoločnosť SinoMab BioScience?
SinoMab BioScience Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of therapeutics for the treatment of immunological diseases, primarily monoclonal antibody (mAb)-based biologics. Its flagship product is SM03, a first-in-target anti-CD22 mAb, which is in Phase III clinical trial for the treatment of rheumatoid arthritis (RA), as well as in various clinical stages for other immunological diseases, such as systemic lupus erythematosus (SLE), Sjogren's syndrome (SS), and non-Hodgkin's lymphoma (NHL). The company also focuses on developing SN1011, a Bruton's tyrosine kinase inhibitor, which is Phase I clinical trial for the treatment of RA, SLE, pemphigus, multiple sclerosis, and other immunological diseases. Its products under preclinical stage comprise SM17 for the treatment of asthma and idiopathic pulmonary fibrosis; SM09 that is used for the treatment of NHL and RA; SM06 for use in treating RA, SLE, and SS; and TNF2 for the treatment of RA. The company operates in Mainland China, the Cayman Islands, and Hong Kong. SinoMab BioScience Limited was incorporated in 2001 and is headquartered in Pak Shek Kok, Hong Kong.
Firmy s metrikou hrubá marža podobnou spoločnosti SinoMab BioScience
- Hodnota metriky Hrubá marža spoločnosti Rua Life Sciences Plc je 78.54%
- Hodnota metriky Hrubá marža spoločnosti Acrow Formwork and Construction Services je 78.56%
- Hodnota metriky Hrubá marža spoločnosti Uniti je 78.57%
- Hodnota metriky Hrubá marža spoločnosti LifeTech Scientific je 78.57%
- Hodnota metriky Hrubá marža spoločnosti Servicenow Dl ,001 je 78.59%
- Hodnota metriky Hrubá marža spoločnosti ServiceNow Inc je 78.59%
- Hodnota metriky Hrubá marža spoločnosti SinoMab BioScience je 78.59%
- Hodnota metriky Hrubá marža spoločnosti Tera Software je 78.59%
- Hodnota metriky Hrubá marža spoločnosti i-nexus Global plc je 78.59%
- Hodnota metriky Hrubá marža spoločnosti F-Secure Oyj je 78.60%
- Hodnota metriky Hrubá marža spoločnosti Magellan je 78.61%
- Hodnota metriky Hrubá marža spoločnosti Prozone Intu Properties je 78.63%
- Hodnota metriky Hrubá marža spoločnosti Pandora AS je 78.63%